Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.43 |
| ▸ | PRKCA | P17252 | 6/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.36 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.36 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sorbitol SCHEMBL3029801 | 0.88 | PRKCA (0.50) | PDE4APRKCALMNAPRKCEPRKCQ | |
| SCHEMBL3692442 | 0.84 | PDE4A (0.54) | PDE4APRKCALMNAL3MBTL1 | |
| SCHEMBL3667118 | 0.83 | PDE4A (0.48) | PDE4APRKCALMNAL3MBTL1 | |
| Triacetin SCHEMBL6398249 | 0.83 | PRKCA (0.44) | PDE4APRKCALMNAL3MBTL1 | |
| SCHEMBL347295 | 0.79 | LMNA (0.48) | PDE4ALMNAL3MBTL1 | |
| SCHEMBL349280 | 0.79 | LMNA (0.48) | PDE4ALMNAL3MBTL1 | |
| SCHEMBL5909539 | 0.79 | LMNA (0.48) | PDE4ALMNAL3MBTL1 | |
| SCHEMBL17608732 | 0.78 | PGD (0.44) | PDE4ALMNA | |
| Hydrochloric Acid SCHEMBL9276429 | 0.78 | PDE4A (0.47) | PDE4ALMNAL3MBTL1 | |
| SCHEMBL8677624 | 0.77 | TDP1 (0.50) | PDE4ALMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011140386-A2 | DETOXIFICATION OF BIOMASS DERIVED ACETATE VIA METABOLIC CONVERSION TO ETHANOL, ACETONE, ISOPROPANOL, OR ETHYL ACETATE | MASCOMA CORPORATION (US) | 2011-11-10 | — | — | WO | disclosed |